Trial site
Okayama
- 10running trials
- 9closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Conditions
- Childhood cancers4 trials
- IgA nephropathy3 trials
- Lung cancer2 trials
- Polymyalgia rheumatica2 trials
- Acute lymphoblastic leukaemia1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Diabetic eye disease1 trial
- Diffuse large B-cell lymphoma1 trial
- Epilepsy1 trial
- Familial hypercholesterolaemia1 trial
- Giant cell arteritis1 trial
- and 5 more
- Phase
- Phase 310 trials
- Status
- Completed9 trials
- Active, not recruiting7 trials
- Recruiting3 trials
- Lead sponsor
- Novartis Pharmaceuticals19 trials
Running trials
Recruiting
Active, not recruiting
Active, not recruiting
Open-label, Long-term Safety Study of Secukinumab in Polymyalgia Rheumatica (PMR)
Recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Childhood cancers2 recruiting
- Acute lymphoblastic leukaemia1 recruiting
- Diffuse large B-cell lymphoma1 recruiting
- Heart failure1 recruiting
Closed trials
Completed
Completed
Completed
Special Drug Use Observational Study With Beovu Kit for Intravitreal Injection
Completed
Completed
Completed
Special Drug-use Surveillance for Kesimpta for s.c. Injection 20 mg Pen
Completed
Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
Completed
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026